{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:18:53Z","timestamp":1778163533229,"version":"3.51.4"},"reference-count":33,"publisher":"American Academy of Implant Dentistry","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>The effect of bevacizumab-related osteonecrosis of the jaw on previously osseointegrated dental implants has not been adequately studied. Here, we report a case of osteonecrosis of the jaw detected around dental implants placed before bevacizumab therapy. A 66-year-old woman undergoing bevacizumab therapy for metastatic triple-negative breast cancer developed malocclusion after buccal gingival swelling and pain in the #18, #19, and #20 tooth region. The patient visited a local dental clinic, where existing implants in relation to #19 and #20 were removed. Subsequently, the patient visited our department, and intraoral examination revealed necrotic bone in the region corresponding to #19 and #20. Radiographic examination showed a pathologic fracture in this region that was considered to result from osteonecrosis of the jaw. Bevacizumab therapy was suspended temporarily until the acute inflammation had subsided. In addition, treatment with antibacterial agents and conservative surgery was considered. Complete soft tissue coverage was observed 14 days after surgery. In recent years, the number of patients receiving bevacizumab treatment has increased. Because bevacizumab-related osteonecrosis of the jaw could occur around previously osseointegrated dental implants as well, this case report suggests an effective treatment regimen based on a combination of antibacterial agents and conservative surgery.<\/jats:p>","DOI":"10.1563\/aaid-joi-d-21-00155","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T09:41:45Z","timestamp":1627378905000},"page":"325-331","source":"Crossref","is-referenced-by-count":9,"title":["Bevacizumab-Associated Implant Presence-Triggered Osteonecrosis: A Case Report and Literature Review"],"prefix":"10.1563","volume":"48","author":[{"given":"Nobuhiro","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiko","family":"Imada","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Okuda","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Nara Medical University, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakaue","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Horita","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Medical Technology Center, Nara Medical University Hospital, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kasahara","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Nara Medical University, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaaki","family":"Kirita","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"434","reference":[{"key":"i1548-1336-48-4-325-b01","series-title":"J Clin Oncol","first-page":"4743","article-title":"Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer","volume":"25","author":"Herbst","year":"2007","unstructured":"Herbst\n              RS,\n            \n            \n              O'Neill\n              VJ,\n            \n            \n              Fehrenbacher\n              L,\n            \n            et al.\n          \n          Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2007;25:4743\u20134750."},{"key":"i1548-1336-48-4-325-b02","series-title":"Ann Oncol","first-page":"2091","article-title":"Bevacizumab-associated osteonecrosis of the jaw","volume":"19","author":"Greuter","year":"2008","unstructured":"Greuter\n              S,\n            \n            \n              Schmid\n              F,\n            \n            \n              Ruhstaller\n              T,\n            \n            \n              Thuerlimann\n              B.\n            \n          \n          Bevacizumab-associated osteonecrosis of the jaw.\n\t\t\t\t\tAnn Oncol.\n\t\t\t\t\t2008;19:2091\u20132092."},{"key":"i1548-1336-48-4-325-b03","series-title":"J Oral Maxillofac Surg","first-page":"1938","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw: 2014 update","volume":"72","author":"Ruggiero","year":"2014","unstructured":"Ruggiero\n              SL,\n            \n            \n              Dodson\n              TB,\n            \n            \n              Fantasia\n              J,\n            \n            et al.\n          \n          American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw: 2014 update.\n\t\t\t\t\tJ Oral Maxillofac Surg.\n\t\t\t\t\t2014;72:1938\u20131956."},{"key":"i1548-1336-48-4-325-b04","series-title":"J Clin Oncol","first-page":"5356","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","unstructured":"Vahtsevanos\n              K,\n            \n            \n              Kyrgidis\n              A,\n            \n            \n              Verrou\n              E,\n            \n            et al.\n          \n          Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2009;27:5356\u20135362."},{"key":"i1548-1336-48-4-325-b05","series-title":"Ann Oncol","first-page":"1341","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","unstructured":"Saad\n              F,\n            \n            \n              Brown\n              JE,\n            \n            \n              Van Poznak\n              C,\n            \n            et al.\n          \n          Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.\n\t\t\t\t\tAnn Oncol.\n\t\t\t\t\t2012;23:1341\u20131347."},{"key":"i1548-1336-48-4-325-b06","series-title":"J Clin Oncol","first-page":"4634","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","unstructured":"Kyrgidis\n              A,\n            \n            \n              Vahtsevanos\n              K,\n            \n            \n              Koloutsos\n              G,\n            \n            et al.\n          \n          Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2008;26:4634\u20134638."},{"key":"i1548-1336-48-4-325-b07","article-title":"Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents? Clin Oral Investig.","author":"Ueda","year":"2020","unstructured":"Ueda\n              N,\n            \n            \n              Nakashima\n              C,\n            \n            \n              Aoki\n              K,\n            \n            et al.\n          \n          Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents? Clin Oral Investig.\n          2020."},{"key":"i1548-1336-48-4-325-b08","article-title":"Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer. J Bone Miner Metab.","author":"Ueda","year":"2021","unstructured":"Ueda\n              N,\n            \n            \n              Aoki\n              K,\n            \n            \n              Shimotsuji\n              H,\n            \n            et al.\n          \n          Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer. J Bone Miner Metab.\n          2021."},{"key":"i1548-1336-48-4-325-b09","series-title":"Int J Oral Maxillofac Surg","first-page":"1397","article-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study","volume":"41","author":"Yamazaki","year":"2012","unstructured":"Yamazaki\n              T,\n            \n            \n              Yamori\n              M,\n            \n            \n              Ishizaki\n              T,\n            \n            et al.\n          \n          Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study.\n\t\t\t\t\tInt J Oral Maxillofac Surg.\n\t\t\t\t\t2012;41:1397\u20131403."},{"key":"i1548-1336-48-4-325-b10","series-title":"J Oral Maxillofac Surg","first-page":"1360","article-title":"Oral Health risk factors for bisphosphonate-associated jaw osteonecrosis","volume":"71","author":"Tsao","year":"2013","unstructured":"Tsao\n              C,\n            \n            \n              Darby\n              I,\n            \n            \n              Ebeling\n              PR,\n            \n            et al.\n          \n          Oral Health risk factors for bisphosphonate-associated jaw osteonecrosis.\n\t\t\t\t\tJ Oral Maxillofac Surg.\n\t\t\t\t\t2013;71:1360\u20131366."},{"key":"i1548-1336-48-4-325-b11","series-title":"PLoS One","first-page":"e0201343","article-title":"Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: is tooth extraction a risk factor?","volume":"13","author":"Soutome","year":"2018","unstructured":"Soutome\n              S,\n            \n            \n              Hayashida\n              S,\n            \n            \n              Funahara\n              M,\n            \n            et al.\n          \n          Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: is tooth extraction a risk factor?\n          \n            PLoS One\n          .\n\t\t\t\t\t2018;13:e0201343."},{"key":"i1548-1336-48-4-325-b12","series-title":"J Craniomaxillofac Surg","first-page":"1945","article-title":"Clinical features of peri-implant medication-related osteonecrosis of the jaw: is there an association to peri-implantitis?","volume":"44","author":"Troeltzsch","year":"2016","unstructured":"Troeltzsch\n              M,\n            \n            \n              Cagna\n              D,\n            \n            \n              St\u00e4hler\n              P,\n            \n            et al.\n          \n          Clinical features of peri-implant medication-related osteonecrosis of the jaw: is there an association to peri-implantitis?\n          \n            J Craniomaxillofac Surg\n          .\n\t\t\t\t\t2016;44:1945\u20131951."},{"key":"i1548-1336-48-4-325-b13","series-title":"J Craniofac Surg","first-page":"697","article-title":"Medication-related osteonecrosis of the jaw around dental implants: implant surgery-triggered or implant presence-triggered osteonecrosis?","volume":"27","author":"Giovannacci","year":"2016","unstructured":"Giovannacci\n              I,\n            \n            \n              Meleti\n              M,\n            \n            \n              Manfredi\n              M,\n            \n            et al.\n          \n          Medication-related osteonecrosis of the jaw around dental implants: implant surgery-triggered or implant presence-triggered osteonecrosis?\n          \n            J Craniofac Surg\n          .\n\t\t\t\t\t2016;27:697\u2013701."},{"key":"i1548-1336-48-4-325-b14","series-title":"J Oral Implantol","first-page":"139","article-title":"Severe case of osteonecrosis following implant placement in a patient in therapy with bisphosphonates: a case report","volume":"45","author":"Storelli","year":"2019","unstructured":"Storelli\n              S,\n            \n            \n              Palandrani\n              G,\n            \n            \n              Dondi\n              C,\n            \n            \n              Tagliatesta\n              L,\n            \n            \n              Rossi\n              A.\n            \n          \n          Severe case of osteonecrosis following implant placement in a patient in therapy with bisphosphonates: a case report.\n\t\t\t\t\tJ Oral Implantol.\n\t\t\t\t\t2019;45:139\u2013144."},{"key":"i1548-1336-48-4-325-b15","article-title":"Medication-related osteonecrosis of the jaw subsequent to periimplantitis: a case report and literature review. J Oral Implantol.","author":"Seki","year":"2020","unstructured":"Seki\n              K,\n            \n            \n              Namaki\n              S,\n            \n            \n              Kamimoto\n              A,\n            \n            \n              Hagiwara\n              Y.\n            \n          \n          Medication-related osteonecrosis of the jaw subsequent to periimplantitis: a case report and literature review. J Oral Implantol.\n          2020."},{"key":"i1548-1336-48-4-325-b16","series-title":"J Oral Maxillofac Surg","first-page":"790","article-title":"Bisphosphonate-related osteonecrosis of the jaw associated with dental implants","volume":"68","author":"Lazarovici","year":"2010","unstructured":"Lazarovici\n              TS,\n            \n            \n              Yahalom\n              R,\n            \n            \n              Taicher\n              S,\n            \n            \n              Schwartz-Arad\n              D,\n            \n            \n              Peleg\n              O,\n            \n            \n              Yarom\n              N.\n            \n          \n          Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.\n\t\t\t\t\tJ Oral Maxillofac Surg.\n\t\t\t\t\t2010;68:790\u2013796."},{"key":"i1548-1336-48-4-325-b17","series-title":"Clin Oral Implants Res","first-page":"632","article-title":"Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment","volume":"25","author":"Kwon","year":"2014","unstructured":"Kwon\n              TG,\n            \n            \n              Lee\n              CO,\n            \n            \n              Park\n              JW,\n            \n            \n              Choi\n              SY,\n            \n            \n              Rijal\n              G,\n            \n            \n              Shin\n              HI.\n            \n          \n          Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.\n\t\t\t\t\tClin Oral Implants Res.\n\t\t\t\t\t2014;25:632\u2013640."},{"key":"i1548-1336-48-4-325-b18","series-title":"J Stomatol Oral Maxillofac Surg","first-page":"40","article-title":"Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: case series and literature review","volume":"121","author":"Escobedo","year":"2020","unstructured":"Escobedo\n              MF,\n            \n            \n              Cobo\n              JL,\n            \n            \n              Junquera\n              S,\n            \n            \n              Milla\n              J,\n            \n            \n              Olay\n              S,\n            \n            \n              Junquera\n              LM.\n            \n          \n          Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: case series and literature review.\n\t\t\t\t\tJ Stomatol Oral Maxillofac Surg.\n\t\t\t\t\t2020;121:40\u201348."},{"key":"i1548-1336-48-4-325-b19","series-title":"Clin Oral Investig","first-page":"271","article-title":"Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings","volume":"14","author":"Hoefert","year":"2010","unstructured":"Hoefert\n              S,\n            \n            \n              Schmitz\n              I,\n            \n            \n              Tannapfel\n              A,\n            \n            \n              Eufinger\n              H.\n            \n          \n          Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.\n\t\t\t\t\tClin Oral Investig.\n\t\t\t\t\t2010;14:271\u2013284."},{"key":"i1548-1336-48-4-325-b20","series-title":"BioMed Res Int","first-page":"8071579","article-title":"Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive-na\u00efve patient: a comprehensive review of the literature","volume":"2018","author":"Pimolbutr","year":"2018","unstructured":"Pimolbutr\n              K,\n            \n            \n              Porter\n              S,\n            \n            \n              Fedele\n              S.\n            \n          \n          Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive-na\u00efve patient: a comprehensive review of the literature.\n\t\t\t\t\tBioMed Res Int.\n\t\t\t\t\t2018;2018:8071579."},{"key":"i1548-1336-48-4-325-b21","series-title":"Curr Osteoporos Rep","first-page":"584","article-title":"Current understanding of the pathophysiology of osteonecrosis of the jaw","volume":"16","author":"Chang","year":"2018","unstructured":"Chang\n              J,\n            \n            \n              Hakam\n              AE,\n            \n            \n              McCauley\n              LK.\n            \n          \n          Current understanding of the pathophysiology of osteonecrosis of the jaw.\n\t\t\t\t\tCurr Osteoporos Rep.\n\t\t\t\t\t2018;16:584\u2013595."},{"key":"i1548-1336-48-4-325-b22","series-title":"Biochem Biophys Res Commun","first-page":"793","article-title":"Vascular endothelial growth factor receptors in osteoclast differentiation and function","volume":"335","author":"Aldridge","year":"2005","unstructured":"Aldridge\n              SE,\n            \n            \n              Lennard\n              TW,\n            \n            \n              Williams\n              JR,\n            \n            \n              Birch\n              MA.\n            \n          \n          Vascular endothelial growth factor receptors in osteoclast differentiation and function.\n\t\t\t\t\tBiochem Biophys Res Commun.\n\t\t\t\t\t2005;335:793\u2013798."},{"key":"i1548-1336-48-4-325-b23","series-title":"J Oncol Pract","first-page":"7","article-title":"Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer","volume":"2","author":"Ruggiero","year":"2006","unstructured":"Ruggiero\n              S,\n            \n            \n              Gralow\n              J,\n            \n            \n              Marx\n              RE,\n            \n            et al.\n          \n          Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.\n\t\t\t\t\tJ Oncol Pract.\n\t\t\t\t\t2006;2:7\u201314."},{"key":"i1548-1336-48-4-325-b24","series-title":"Lancet Oncol","first-page":"508","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment","volume":"7","author":"Migliorati","year":"2006","unstructured":"Migliorati\n              CA,\n            \n            \n              Siegel\n              MA,\n            \n            \n              Elting\n              LS.\n            \n          \n          Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.\n\t\t\t\t\tLancet Oncol.\n\t\t\t\t\t2006;7:508\u2013514."},{"key":"i1548-1336-48-4-325-b25","series-title":"J Oral Maxillofac Surg","first-page":"415","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","unstructured":"Mavrokokki\n              T,\n            \n            \n              Cheng\n              A,\n            \n            \n              Stein\n              B,\n            \n            \n              Goss\n              A.\n            \n          \n          Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.\n\t\t\t\t\tJ Oral Maxillofac Surg.\n\t\t\t\t\t2007;65:415\u2013423."},{"key":"i1548-1336-48-4-325-b26","series-title":"Eur J Cancer","first-page":"3082","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","unstructured":"Lipton\n              A,\n            \n            \n              Fizazi\n              K,\n            \n            \n              Stopeck\n              AT,\n            \n            et al.\n          \n          Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.\n\t\t\t\t\tEur J Cancer.\n\t\t\t\t\t2012;48:3082\u20133092."},{"key":"i1548-1336-48-4-325-b27","series-title":"N Engl J Med","first-page":"2666","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","unstructured":"Miller\n              K,\n            \n            \n              Wang\n              M,\n            \n            \n              Gralow\n              J,\n            \n            et al.\n          \n          Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2007;357:2666\u20132676."},{"key":"i1548-1336-48-4-325-b28","series-title":"26:abstract LBA1011.","article-title":"Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO. J Clin Oncol.","author":"Miles","year":"2008","unstructured":"Miles\n              D,\n            \n            \n              Chan\n              A,\n            \n            \n              Romieu\n              G,\n            \n            et al.\n          \n          Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO. J Clin Oncol.\n          2008;\n\t\t\t\t\t26:abstract LBA1011."},{"key":"i1548-1336-48-4-325-b29","series-title":"RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab (B) for first-line treatment of HER2-negative locally recurrent or metastatic breast cancer (MBC). J Clin Oncol.","author":"Robert","year":"2009","unstructured":"Robert\n              NJ,\n            \n            \n              Dieras\n              V,\n            \n            \n              Glaspy\n              J,\n            \n            et al.\n          \n          RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab (B) for first-line treatment of HER2-negative locally recurrent or metastatic breast cancer (MBC). J Clin Oncol.\n          2009;\n\t\t\t\t\t27:abstract 1005."},{"key":"i1548-1336-48-4-325-b30","series-title":"Breast Cancer Res Treat","first-page":"181","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","unstructured":"Guarneri\n              V,\n            \n            \n              Miles\n              D,\n            \n            \n              Robert\n              N,\n            \n            et al.\n          \n          Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.\n\t\t\t\t\tBreast Cancer Res Treat.\n\t\t\t\t\t2010;122:181\u2013188."},{"key":"i1548-1336-48-4-325-b31","series-title":"Int J Implant Dent","first-page":"34","article-title":"A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants","volume":"5","author":"Maluf","year":"2019","unstructured":"Maluf\n              G,\n            \n            \n              Caldas\n              RJ,\n            \n            \n              Fregnani\n              ER,\n            \n            \n              da Silva Santos\n              PS.\n            \n          \n          A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants.\n\t\t\t\t\tInt J Implant Dent.\n\t\t\t\t\t2019;5:34."},{"key":"i1548-1336-48-4-325-b32","series-title":"Eur J Surg Oncol","first-page":"737","article-title":"Review: incidence and clinical significance of bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer","volume":"37","author":"Hompes","year":"2011","unstructured":"Hompes\n              D,\n            \n            \n              Ruers\n              T.\n            \n          \n          Review: incidence and clinical significance of bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.\n\t\t\t\t\tEur J Surg Oncol.\n\t\t\t\t\t2011;37:737\u2013746."},{"key":"i1548-1336-48-4-325-b33","series-title":"Lancet Oncol","first-page":"373","article-title":"Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care","volume":"11","author":"Bose","year":"2010","unstructured":"Bose\n              D,\n            \n            \n              Meric-Bernstam\n              F,\n            \n            \n              Hofstetter\n              W,\n            \n            \n              Reardon\n              DA,\n            \n            \n              Flaherty\n              KT,\n            \n            \n              Ellis\n              LM.\n            \n          \n          Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.\n\t\t\t\t\tLancet Oncol.\n\t\t\t\t\t2010;11:373\u2013382."}],"container-title":["Journal of Oral Implantology"],"original-title":[],"link":[{"URL":"https:\/\/joi.kglmeridian.com\/view\/journals\/orim\/48\/4\/article-p325.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/joi\/article-pdf\/48\/4\/325\/3124722\/i1548-1336-48-4-325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/joi.kglmeridian.com\/downloadpdf\/journals\/orim\/48\/4\/article-p325.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/joi.kglmeridian.com\/downloadpdf\/journals\/orim\/48\/4\/article-p325.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:19:41Z","timestamp":1752193181000},"score":1,"resource":{"primary":{"URL":"https:\/\/joi.kglmeridian.com\/view\/journals\/orim\/48\/4\/article-p325.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":33,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1563\/aaid-joi-d-21-00155","relation":{},"ISSN":["1548-1336","0160-6972"],"issn-type":[{"value":"1548-1336","type":"electronic"},{"value":"0160-6972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}